
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Levothyroxine Sodium
Therapeutic Area : Oncology
Study Phase : Phase IV
Recipient : UT Southwestern Medical Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Levothyroxine Replacement With Liquid Gel Capsules vs Tablets Post-thyroidectomy
Details : Levothyroxine is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Thyroid Neoplasms.
Product Name : Undisclosed
Product Type : Amino Acid
Upfront Cash : Inapplicable
October 27, 2016
Lead Product(s) : Levothyroxine Sodium
Therapeutic Area : Oncology
Highest Development Status : Phase IV
Recipient : UT Southwestern Medical Center
Deal Size : Inapplicable
Deal Type : Inapplicable
